340C was designed by community health center officials to benefit health centers and other covered entities, while also answering the call for greater transparency in the 340B Drug Pricing Program. ACH’s 340C legislative proposal does not favor one type of covered entity over another; all are welcome to opt in in order to gain protections from actions that reduce 340B’s value.

Despite its importance, the 340B program is facing challenges from various sources, including state policymakers, pharmaceutical companies, and pharmacy benefit managers. These challenges threaten the ability of health centers to leverage the program effectively.

Advocates for Community Health invites you to learn more about ensuring access to care for underserved patients and communities with 340C.

Download our white paper

Next Article